EVA Nexus Vitrectomy Device Field Observation Study

Clinical Trial Description

To perform a field observation study using the newly developed EVA Nexus vitrectomy device. Patients that are scheduled for intra-ocular surgery regardless of the indication: - Vitrectomy surgery - Cataract surgery - Vitrectomy combined with cataract surgery ;

Study Design

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04570007` - Vitreous Fragments Length After Pars Plana Vitrectomy
Recruiting	`NCT06160960` - Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome
Completed	`NCT05427526` - Outcome of Zeiss AT LARA EDOF Lens Implantation in Vitrectomized Eyes	N/A
Active, not recruiting	`NCT05583331` - Comparison of Two Surgical Sequences "Cataract Surgery Then Vitrectomy" Versus "Vitrectomy Then Cataract Surgery" Under Local-regional Anesthesia	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT04570007 - Vitreous Fragments Length After Pars Plana Vitrectomy

Recruiting

NCT06160960 - Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome

Completed

NCT05427526 - Outcome of Zeiss AT LARA EDOF Lens Implantation in Vitrectomized Eyes

N/A

Active, not recruiting

NCT05583331 - Comparison of Two Surgical Sequences "Cataract Surgery Then Vitrectomy" Versus "Vitrectomy Then Cataract Surgery" Under Local-regional Anesthesia

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05229094
Study type	Observational
Source	Universitaire Ziekenhuizen Leuven
Contact
Status	Completed
Phase
Start date	May 22, 2021
Completion date	April 1, 2022

EVA Nexus Vitrectomy Device Field Observation Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms